A new report from the U.S. Drug Enforcement Agency (DEA) warns fentanyl “super laboratories” in Canada are “a growing concern for the United States,” particularly as production and supply from Mexico is disrupted.
The DEA’s latest annual Drug Threat Assessment says that while the flow of fentanyl from Canada into the U.S. is far lower than from Mexico, Canadian opioid production has the potential to expand and fill the “supply void” from south of the U.S. border.
“In addition to the synthetic drug threat from Mexico, elevated synthetic drug production in Canada — particularly from sophisticated fentanyl ‘super laboratories’ … presents a growing concern for the United States,” the report states.
U.S. President Donald Trump has laid sweeping tariffs on Canada and Mexico over concerns about the flow of fentanyl into the U.S., citing a national emergency he declared over the drug crisis.
Story continues below advertisement
Although overdose deaths fell a record 27 per cent year-over-year in 2024, according to …